发明名称 |
Use of cd34+ hematopoietic progenitor cells for the treatment of cns disorders |
摘要 |
The present invention provides novel methods for delivering cells, particularly modified cells to the central nervous system (CNS). The purpose of this invention is to present a method that provides sustained delivery of a molecule to the central nervous system, thereby increasing the bioavailability of the molecule and lengthening the possible duration of treatment.
|
申请公布号 |
US2005163760(A1) |
申请公布日期 |
2005.07.28 |
申请号 |
US20040501738 |
申请日期 |
2004.07.16 |
申请人 |
CARTIER-LACAVE NATHALIE;AUBOURG PATRICK;ASHUEUR MURIEL;BENHAMIDA SONIA;PFLUMIO FRANCOISE |
发明人 |
CARTIER-LACAVE NATHALIE;AUBOURG PATRICK;ASHUEUR MURIEL;BENHAMIDA SONIA;PFLUMIO FRANCOISE |
分类号 |
A61K35/12;A61K38/00;A61K48/00;A61P25/28;C07K14/47;C07K14/705;C12N5/0789;(IPC1-7):A61K48/00;C12N5/08 |
主分类号 |
A61K35/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|